non-small cell lung cancer
Conditions
Interventions
1:Large split SIB-IMRT
Sponsors
Shandong Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) Histopathology demonstrated NSCLC, staging examinations for the T1-2N0M0, reject or difficult to tolerate surgery; 2) ECOG 0-1 grade; life expectancy of> 6 months; 3) Aged 18-75 years old, male or female, if in good physical condition, age may be relaxed; 4) No history of radiotherapy and chemotherapy; 5) No serious complications, such as hypertension, coronary heart disease and mental illness, no history of severe allergies; 6) Hb >=100 g/L; WBC>=3.5*10^9/L, Neutrophils>=1.5*10^9, Plt>=100*10^9/L; CR>=1.5*Upper limit of normal, TB>=2.5 times of Upper limit of normal, AST and ALT>=2.5 times of Upper limit of normal, AKP>=2.5 times of Upper limit of normal; 7) Signed informed consent.
Exclusion criteria
Exclusion criteria: 1) Other parts of the malignancy; 2) Pregnant or lactating patients; 3) Childbearing potential but not used contraception; 4) Serious complications: a large area of myocardial infarction, cardiac function >=II level, history of mental illness and severe diabetes; 5) Within four weeks prior to the current or selected to participate in other clinical trials; 6) The same time with other anti-cancer drug therapy (including anti-cancer Traditional Chinese medicine); 7) A history of organ transplantation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| survival rate;toxic and side effect; | — |
Countries
China
Contacts
Public ContactBaosheng Li
Outcome results
None listed